CalciMedica Inc CALC

Healthcare

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).

NDAQ:CALC - Post by User

CalciMedica Inc > this is a real gold mine!! lets make sell orders 6$ plus

<< Previous

Bullboard Posts

Next >>

Comment by cigar9999moneyon Apr 10, 2021 8:34am

503 Views

Post# 32972316

RE:RE:this is a real gold mine!! lets make sell orders 6$ plus

It is not purely spculation,drills 5.51 g/t over 4,60 mtres NEAR SURFACE
Aquisition of key mining leases at Shakespeare gold ( 98 hectares of very prospective and strategic ground
Yes after 6 to 9 dollars il will have correction until phase 2 rsults then it will ven go higher

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle